Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF SEPTEMBER 05, 2019 FBO #6493
SOLICITATION NOTICE

66 -- Robot Stereotaxic System

Notice Date

9/3/2019
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

334519 — Other Measuring and Controlling Device Manufacturing
 

Contracting Office

Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
 

ZIP Code

20892-9559
 

Solicitation Number

HHS-NIH-NIDA-OA-19-009190-CSS
 

Point of Contact

Debra C. Hawkins, Phone: 301-827-7751
 

E-Mail Address

debra.hawkins@nih.gov
(debra.hawkins@nih.gov)
 

Small Business Set-Aside

N/A
 

Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is HHS-NIH-NIDA-OA-19-009190-CSS and the solicitation is issued as a Request for Quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures and FAR Part 12-Acquisition of Commercial Items. This acquisition is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition on behalf of the National Institute of Neurological Disorders and Strokes (NINDS) intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to Neurostar GmbH, Kahnerweg 1, 72072 Tubingen, Germany, for a Robot Stereotaxic System. This acquisition is conducted as non-competitive for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1 (b) Soliciting from a single source. (1) For purchases not exceeding the simplified acquisition threshold, contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, or industrial mobilization). The rationale for the brand name justification is the unique capabilities of the requested product. (iii) This solicitation incorporates the provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-05, effective August 13, 2019. (iv) The associated North American Industry Classification System (NAICS) code: 334519- Other Measuring and Controlling Device Manufacturing, Size Standard: 500 employees. (v) Robot Stereotaxic System (vi) Background / Purpose / Objective: The National Institute of Neurological Disorders and Strokes (NINDS) requires stereotaxic frames for precise intracranial viral vector and drug injections as well as canula implantation in rodents and non-human primates (marmosets). The purpose of this equipment is to enable NINDS to micro-inject small volumes (starting from 1 nanoliter) of viral vectors, neuronal tracers, or drugs accurately into regions of interests. This apparatus must be integrated with automatic controllers to minimize human error of injectors within a comprehensive state-control system that can record and control behaviorally-relevant events in the experimental environment. NINDS will study voluntary breathing and vocalization in freely behaving rodents and non-human primates, using chronically implanted electrodes or fiber optics, which allow NINDS to monitor synchronized activities from specialized regions of the brain using single or multiple electrode/optrode arrays. Presently NINDS seek to acquire an automated drill & microinjection stereotaxic instrument for automated drilling, followed by ultraprecise injection of small volumes (starting from 1 nl). The injection of viral vector-based expression of genetically encoded calcium indicators (GECI) is an essential step before implanting fiber optics and record Ca2+ activities in brain cells. In addition to these essential features of injection, the automated drilling feature should enable NINDS to make a craniotomy window or skull thinning features with high accuracy positioning. Consequently, such procedures are essential to NINDS program's objectives, which include the characterization of functional architecture of brain circuits for breathing and vocalization in freely-moving animals. As such, a system is required with (1) automated drilling with auto-stop function to prevent damages to the brain, (2) a nanoliter injection capability to inject small volumes, (3) capability to be used in both rodents and marmosets, (4) correction for head-tilt errors. Specifications: Robot Stereotaxic System manufactured by Neurostar GmbH, Kahnerweg 1, 72072 Tubingen, Germany, Telephone: +49-7071-770-4460, Fax: +49-7071-770-4463, email address: www.neurostar.de; web site info@neurostar.de, includes the following minimum specifications: (1) Drill & Nanoinjection Robot including Drill Autostop Function which includes: Interconnected Automated Drill and Glass-Capillary Nanoinjector with Including Robot Stereotaxic System, Full control by the Robot Stereotaxic software (included), Full Integrated Stereotaxic Atlas, Zeroing at Lambda/Bregma, Correction for Tilt Errors, Individual Atlas Scaling, Intuitive Movement Control, Drill Autostop function, Automated drilling procedure without damaging the underlying brain tissue, High accuracy positioning of Burr Hole with depth control, No tool exchange after drilling required, Use of Bregma-related coordinates, Glass-Capillary Ultraprecise Nanoinjector, Computer controlled, intuitive interface User defined Injection Volumes, User defined Injection Rates, Uses direct piston displacement, Robot Mode, Multisite Nanoinjections, Real-time atlas-based visualization of capillary tip and injection sites, No animal adaptor, ear bars and head holder included, and Compatible with Microsoft Windows 10; (2) Drill Automated Craniotomy Function to perform craniotomy procedures; (3) Automated synchronization device for cannula and drill bit to allow automated synchronization between the drill and syringe with optical detection of the drill bit and of the syringe needle; (4) Smart BregmaFinder with a Dual Camera System for high resolution 3D real-time probe monitoring, Automatic, Hands-Free, Precise positioning of the Probe over landmark, Smart Add-On to the Motorized Stereotaxic with Atlas Integration; (5) Cube3 - Manual Remote Control of Robot Stereotaxic for Intelligent Remote Control of the Robot Stereotaxic; (6) Mouse Gas Anesthesia Head Holder; (7) Non-Rupture Ear Bars (Mouse) with a 60° Non-Rupture tip; (8) Rat Adaptor; (9) Rat Anesthesia Mask; (10) Non-Rupture Ear Bars (Rat) with 45° Non-Rupture tip with a 0.8 mm radius; and (11) Integration of the Marmoset Atlas into the StereoDrive software. (vii) Government's Anticipated Delivery: Within four (4) to six (6) weeks After Receipt of Order (ARO). Delivery Point: FOB Destination. Delivery Location: National Institute of Neurological Disorders and Strokes, Bethesda, Maryland 20892. The successful offeror shall coordinate delivery arrangements with the customer prior to shipment. The Loading Dock hours are as follows: 8:00 am to 4:30 pm Eastern Time, Monday through Friday except on Federal holidays. All products delivered must contain a Packing Slip (with serial numbers as applicable). (viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. (ix) The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The factors used to evaluate offers are the unique technical and performance capabilities of product and cost. Technical and past performance, when combined, are significantly more important than cost or price. (x) Offerors are advised to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications - Commercial Items, with its offer. (xi) FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. (xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items, applies to this acquisition. (xiii) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition (xiv) Defense Priorities and Allocations System (DPAS) and assigned rating, is not applicable to this solicitation. (xv) All quotations or offers are due 12:00 Noon, Eastern Time, on September 9, 2019, and must reference the solicitation number noted herein. Quotations or offers must be submitted electronically to the contact person identified herein at debra.hawkins@nih.gov. Fax responses will not be accepted. (xvi) For information regarding this solicitation contact: Debra C. Hawkins Contractor, Acquisition Policy Analyst II, at 301-827-7751.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-OA-19-009190-CSS /listing.html)
 

Place of Performance

Address: National Institute of Neurological Disorders and Strokes, Bethesda, Maryland 20892., Bethesda, Maryland, 20892, United States

Zip Code: 20892
 

Record

SN05428133-W 20190905/190903230941-9bb506483e232b21a06491861e4ed263 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |